SYN - Synthetic Biologics Inc. (SYN) CEO Steven Shallcross on Q3 2019 Results - Earnings Call Transcript
Synthetic Biologics, Inc. (SYN)
Q3 2019 Earnings Conference Call
November 04, 2019, 16:30 PM ET
Company Participants
Vincent Perrone - Director, Corporate Communications
Steven Shallcross - CEO and CFO
Michael Kaleko - SVP of Research and Development
Vince Wacher - Head of Product and Corporate Development
Conference Call Participants
Jim Molloy - Alliance Global Partners
Presentation
Operator
Good afternoon and welcome to Synthetic Biologics' 2019 Third Quarter Investor Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded.
At this time, I would like to turn the